Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optical and Biochemical Biomarkers in Early Pancreatic Cancer Significance: A Prospective Study

NCT03404661 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03404661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03404661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optical and Biochemical Biomarkers in Early Pancreatic Cancer Significance: A Prospective Study
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
January 11, 2018
Completion date
March 10, 2022
Enrollment
346 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer